Literature DB >> 29217069

Infantile Hemangiomas in the Head and Neck Region.

Denise M Adams1, Kiersten W Ricci2.   

Abstract

Infantile hemangiomas (IHs) are benign vascular tumors of infancy most common in the region of the head and neck. Infantile hemangiomas are common; but they are extremely heterogeneous and cause a range of complications depending on their morphology, size, or location. Medical interventions for high-risk patients include topical and systemic therapies, including oral propranolol, which has revolutionized the management of IHs over the past recent years. In the following article, the authors aim to provide a review of the natural history, pathology, complications, syndromes, and medical management of infantile hemangioma.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Focal; Hepatic hemangioma; Infantile hemangioma; Propranolol; Segmental/regional/diffuse hemangioma; Timolol

Mesh:

Substances:

Year:  2018        PMID: 29217069     DOI: 10.1016/j.otc.2017.09.009

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  5 in total

1.  An ulcerated giant segmental hemangioma resulting in contracture of the left elbow.

Authors:  Alexander K C Leung; Kin Fon Leong; Joseph M Lam
Journal:  Paediatr Child Health       Date:  2020-04-24       Impact factor: 2.253

2.  Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol.

Authors:  Changhua Wu; Lei Guo; Liang Wang; Jing Li; Changfeng Wang; Dan Song
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 3.  Effects of sclerosing agents on head and neck hemangiomas: A systematic review.

Authors:  Rúbia-Teodoro Stuepp; Fernanda-Marcello Scotti; Gilberto Melo; Etiene-de Andrade Munhoz; Filipe Modolo
Journal:  J Clin Exp Dent       Date:  2019-11-01

4.  Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma.

Authors:  Caroline T Seebauer; Matthew S Graus; Lan Huang; Alex McCann; Jill Wylie-Sears; Frank Fontaine; Tara Karnezis; David Zurakowski; Steven J Staffa; Frédéric Meunier; John B Mulliken; Joyce Bischoff; Mathias Francois
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

5.  MiR-200c-3p increased HDMEC proliferation through the notch signaling pathway.

Authors:  Xianyu Hu; Suwen Bai; Lingyi Li; Pengfei Tian; Sun Wang; Ning Zhang; Bing Shen; Juan Du; Shengxiu Liu
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.